The novel approach of the medication represents a significant development in the care of diabetes mellitus type 2. Different to existing medications, tirzepatide targets two pathways – GLP-1 and GIP – providing https://tirzepatidepeptide591403.widblog.com/96924857/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment